about
Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)Emerging Influenza Strains in the Last Two Decades: A Threat of a New Pandemic?Self-Folding of Naked Segment 8 Genomic RNA of Influenza A VirusIntranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protectionClinical vaccine development for H5N1 influenza.Tackle the problem when it gets here: pandemic preparedness among small and medium businesses.Universal influenza vaccines, a dream to be realized soon.New pre-pandemic influenza vaccines: an egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice.Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 ExpressionDevelopment of a vaccine against pandemic influenza viruses: current status and perspectives.Current status and progress of prepandemic and pandemic influenza vaccine development.Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin.Influenza nucleoprotein delivered with aluminium salts protects mice from an influenza A virus that expresses an altered nucleoprotein sequence.Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.HA-pseudotyped retroviral vectors for influenza antagonist screening.H5N1 avian influenza re-emergence of Lake Qinghai: phylogenetic and antigenic analyses of the newly isolated viruses and roles of migratory birds in virus circulationPotent neutralization of influenza A virus by a single-domain antibody blocking M2 ion channel protein.Novel linear DNA vaccines induce protective immune responses against lethal infection with influenza virus type A/H5N1.Selection of therapeutic H5N1 monoclonal antibodies following IgVH repertoire analysis in mice.Characterization of the H5N1 highly pathogenic avian influenza virus derived from wild pikas in China.Emergence of viral diseases: mathematical modeling as a tool for infection control, policy and decision making.Some considerations concerning the challenge of incorporating social variables into epidemiological models of infectious disease transmission.Synthesis and In Vitro Anti-Influenza Virus Evaluation of Novel Sialic Acid (C-5 and C-9)-Pentacyclic Triterpene Derivatives.Hypothiocyanite produced by human and rat respiratory epithelial cells inactivates extracellular H1N2 influenza A virus.Knowledge, attitudes, and poultry-handling practices of poultry workers in relation to avian influenza in IndiaAvian influenza viruses detected by surveillance of waterfowl in Ireland during 2003-2007.Virological surveillance of the influenza A(H1N1)2009 pandemic: the role of the belgian national influenza centre.Emerging vaccines for influenza
P2860
Q24645944-EA193E12-F9E6-4C1E-8CF3-16C3318BCFF7Q26783481-F2FA6259-E17A-4E46-8864-89BC806CB1D8Q28553150-CF102E4C-81D0-426E-867D-9F3BBE7213F8Q28744570-DD6169F4-4AEB-4D4A-BA76-C3128958118EQ30222083-12E8C5EF-83D2-4555-9FF2-224C2B1135EBQ30228880-2A122494-3B37-4CE6-8B3E-B384F140D7E6Q30361950-67F5F436-C6F0-4948-B256-5F24DF4D9B9DQ30365380-D0FB2BDA-D1B8-4496-B053-880DDBC3625AQ30371866-121E8FF4-A5E6-49D1-B661-B35E5E2FC6BFQ30372625-D4BE70FA-CA33-49D4-9ED0-F174DE0A3F2AQ30373784-CFB30E92-BD64-4299-96F0-72D6D333CF2FQ30375975-D4D7998D-F74C-42EB-8DF6-ABF24259E874Q30379493-634C0E84-5E28-42AF-9892-C639431487DEQ30429719-50220418-138D-49EA-98AA-1D0DAEEB76BFQ30474419-88E1AD2E-042F-4B5E-8226-1BB9E899ABDEQ33408475-484CDB64-2245-4417-AA17-CA770C1C94D8Q33913582-BBAACBA8-CD3C-46E8-9D90-DF93633A6CA3Q34099149-CE0AAC1E-3174-4076-810D-E7D5372289A2Q37001633-70E5B987-5C77-4C87-89B8-33195923003DQ37069543-0CF0FB37-0E49-4EE5-9DB1-F8D03CE526DAQ37333829-EB23E446-C345-4C51-A11E-9BE29876EB6BQ37706540-4F80CFB0-3AAB-4395-8E4E-83DBF126D22EQ38343120-53C4AA2D-0D70-4A72-BC24-DAA03DFF5B38Q38699365-0E29198F-CD0B-412A-9DBB-63BEDA6515A5Q40273625-A2EB61FF-847A-4A57-AE84-6F25AB17E723Q42245927-0DE5653E-7954-445E-8269-1929BCA8CFB8Q51678913-C11E1B99-700D-4526-8D3C-2534F38F106AQ55646788-30004ECF-B75A-41A2-ADBD-5FF159865641Q57112739-6913C6CC-7ED5-4A0D-AAE9-95A84ED8B890
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Avian and pandemic influenza: an overview.
@ast
Avian and pandemic influenza: an overview.
@en
type
label
Avian and pandemic influenza: an overview.
@ast
Avian and pandemic influenza: an overview.
@en
prefLabel
Avian and pandemic influenza: an overview.
@ast
Avian and pandemic influenza: an overview.
@en
P1433
P1476
Avian and pandemic influenza: an overview.
@en
P2093
Paul V Targonski
Robert M Jacobson
P304
P356
10.1016/J.VACCINE.2007.01.050
P407
P577
2007-01-18T00:00:00Z